OTCMKTS:NSTM NovelStem International (NSTM) Stock Price, News & Analysis → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free NSTM Stock Alerts $0.06 0.00 (0.00%) (As of 05/8/2024 ET) Add Compare Share Share Today's Range$0.06▼$0.0650-Day Range$0.06▼$0.0752-Week Range$0.06▼$0.28VolumeN/AAverage Volume230 shsMarket Capitalization$2.81 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsSEC FilingsStock AnalysisChartEarningsFinancialsSEC Filings Get NovelStem International alerts: Email Address Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. About NovelStem International Stock (OTCMKTS:NSTM)NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was incorporated in 1993 and is based in Boca Raton, Florida.Read More NSTM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NSTM Stock News HeadlinesJuly 13, 2023 | finance.yahoo.comArbitration Confirms NovelStem Joint Venture's Rights to Exploit 'Tom Clancy's Net Force' Franchise Globally via Film, TV, Online, Streaming, Gaming and MerchandisingApril 24, 2023 | forbes.comGlencore InternationalMay 9, 2024 | Crypto 101 Media (Ad)Tech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. March 31, 2023 | finance.yahoo.comNovelStem, Focused on a Patented Genetic Platform Technology for Anti-Cancer Therapies, Reports 2022 Results on Form 10-KDecember 14, 2022 | finance.yahoo.comNovelStem's Affiliate NewStem Announced New Collaboration to Validate Its Software Diagnostic Device for Two Oncology Indications and Two TherapiesOctober 20, 2022 | finance.yahoo.comNovelStem International Corp. (NSTM)October 13, 2022 | finance.yahoo.comNovelStem Now an SEC-Reporting Company, Secures Commitment for up to $600K in Bridge Funding, Provides Financial UpdateAugust 27, 2022 | reuters.comNovelstem International CorpMay 9, 2024 | Crypto 101 Media (Ad)Tech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. April 15, 2022 | yahoo.comBreast cancer survivor says her sports bra saved her lifeApril 14, 2022 | yahoo.com9 Things That Millennials Who Grew Up In Puerto Rico Will RememberApril 14, 2022 | yahoo.comLatinx People Are Sharing Are Sharing "Untraditional" Beauty Tips From Their Abuelas And Moms, And I'm Taking NotesApril 11, 2022 | finance.yahoo.comNovelStem Announces FDA Pre-Submission and EMA In Vitro Diagnostic Device Filing for Revolutionary Life-Saving, Treatment-Changing Diagnostic Device by 30%-Owned NewStem, LtdFebruary 17, 2022 | yahoo.comCampaigns With Heart Honored As 2022 Halo Award FinalistsFebruary 17, 2022 | yahoo.comMedi-Weightloss Celebrates Growth and Prepares for Expansion in 2022February 15, 2022 | finance.yahoo.comNovelStem Reviews Efforts to Maximize Value from Legacy Entertainment AssetJanuary 23, 2022 | nasdaq.comNovelStem International Corp (NSTM)See More Headlines Receive NSTM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NovelStem International and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Retail stores, not elsewhere classified Sub-IndustryN/A Current SymbolOTCMKTS:NSTM CUSIPN/A CIK912544 Webwww.novelstem.com Phone410-654-3315Fax561-998-2974Employees15Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-4,190,000.00 Net MarginsN/A Pretax Margin-32,375.00% Return on Equity-2,613.09% Return on Assets-195.20% Debt Debt-to-Equity RatioN/A Current Ratio0.25 Quick Ratio0.25 Sales & Book Value Annual Sales$10,000.00 Price / Sales281.28 Cash FlowN/A Price / Cash FlowN/A Book Value$0.04 per share Price / Book1.50Miscellaneous Outstanding Shares46,880,000Free FloatN/AMarket Cap$2.81 million OptionableNot Optionable Beta0.15 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesMr. Jan H. Loeb (Age 65)Executive Chairman & President Mr. Mitchell Rubenstein (Age 70)Co-Founder & Independent Director Ms. Christine Jenkins (Age 60)VP, CFO & Secretary Comp: $54kMr. David CollinsInvestor Relations Firm, Catalyst IRKey CompetitorsiSpecimenNASDAQ:ISPCQuoin PharmaceuticalsNASDAQ:QNRXCyclacel PharmaceuticalsNASDAQ:CYCCAgile TherapeuticsNASDAQ:AGRXFSD PharmaOTCMKTS:FSDDFView All Competitors NSTM Stock Analysis - Frequently Asked Questions How have NSTM shares performed in 2024? NovelStem International's stock was trading at $0.0629 at the beginning of the year. Since then, NSTM shares have decreased by 4.6% and is now trading at $0.06. View the best growth stocks for 2024 here. How do I buy shares of NovelStem International? Shares of NSTM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:NSTM) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressObama’s Forever Term [exposed]Porter & CompanyThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill Publishing348 million Americans lives to END as we know it?The Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NovelStem International Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
